Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Engineered bat virus stirs debate over risky research 

Subjects

Lab-made coronavirus related to SARS can infect human cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Menachery, V. D. et al. Nature Med. http://dx.doi.org/10.1038/nm.3985 (2015).

  2. Ge, X.-Y. et al. Nature 503, 535–538 (2013).

    Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Authors

Additional information

Tweet Follow @NatureNews

Editors’ note, March 2020 We are aware that this story is being used as the basis for unverified theories that the novel coronavirus causing COVID-19 was engineered. There is no evidence that this is true; scientists believe that an animal is the most likely source of the coronavirus.

Related links

Related links

Related links in Nature Research

Viral-research moratorium called too broad 2014-Oct-23

US suspends risky disease research 2014-Oct-22

Biosafety in the balance 2014-Jun-25

Related external links

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Butler, D. Engineered bat virus stirs debate over risky research . Nature (2015). https://doi.org/10.1038/nature.2015.18787

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2015.18787

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing